PREVIOUS
✖
New Obesity Treatment Options
December 25 , 2024
16 hrs 0 min
59
0
- The WHO approved GLP-1 receptor agonists as a treatment for obesity, such as semaglutide and tirzepatide.
- They will mimic hormones that regulate appetite and blood sugar.
- The WHO emphasizes that while healthy eating and exercise are crucial, they alone cannot solve the obesity epidemic.
- In 2022, one in eight people worldwide was classified as obese, totalling 890 million adults and 160 million adolescents.
- In India, 44 million women and 26 million men were affected by obesity in 2022.
Leave a Reply
Your Comment is awaiting moderation.